Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is highly rated in 16 conditions, according to our data. His top areas of expertise are Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Roberto Salvatori is an Endocrinologist in Baltimore, Maryland. Dr. Salvatori is highly rated in 42 conditions, according to our data. His top areas of expertise are Growth Hormone Deficiency (GHD), Hypopituitarism, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT).

Errol Rushovich is an Endocrinologist in Baltimore, Maryland. Dr. Rushovich is highly rated in 25 conditions, according to our data. His top areas of expertise are Hypothyroidism, Obesity in Children, Type 2 Diabetes (T2D), and Osteoporosis.

Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is highly rated in 20 conditions, according to our data. His top areas of expertise are Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Thyroidectomy.

William Simonds is an Endocrinologist in Baltimore, Maryland. Dr. Simonds is highly rated in 10 conditions, according to our data. His top areas of expertise are Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia, Parathyroid Adenoma, Parathyroidectomy, and Thymectomy.

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is highly rated in 9 conditions, according to our data. Her top areas of expertise are Hypogonadism, Eunuchoidism Familial Hypogonadotropic, Testicular Failure, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT).

Rexford Ahima is an Endocrinologist in Baltimore, Maryland. Dr. Ahima is highly rated in 3 conditions, according to our data. His top areas of expertise are Obesity, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Sleeve Gastrectomy, and Gastric Bypass.

Amir Hamrahian, M.D. is an endocrinologist with specialized experience in the treatment of adrenal and pituitary disorders. Dr. Hamrahian is located in Baltimore, Maryland. He received his medical degree from Hacettepe University in Ankara, Turkey, did his internal medicine residency at the University of North Dakota and completed his endocrinology fellowship at the Case Western Reserve University. Dr. Hamrahian is an Associate Professor of Medicine and has published more than 80 peer-reviewed articles, and has served as a co-author in developing guidelines for adrenal and pituitary disorders. He has presented at national and international conferences and has served as the principal investigator for a number of clinical research studies. Accolades received include Teacher of The Year award and Human Subject Research Annual Professional Excellence award in 2003 and 2011, respectively. Dr. Hamrahian has held roles including the chief of endocrinology in Abu Dhabi. Dr. Hamrahian is a co-director of the Adrenal Center. Dr. Hamrahian is highly rated in 32 conditions, according to our data. His top areas of expertise are Cushing's disease, Pituitary Tumor, Cushing's syndrome, Ectopic Cushing's syndrome, and Gamma Knife Radiosurgery.

Dr. Han Na Kim is a Clinical Associate and part-time Assistant Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism. Her clinical practice focuses on metabolic bone disease, including osteoporosis and hyperparathyroidism, as well as diabetes mellitus. She earned her medical degree from the University of Chicago Pritzer School of Medicine, completed her residency in Internal Medicine at New York University, and worked as a hospitalist at University of Pittsburgh Medical Center Presbyterian/Montefiore before pursuing an endocrinology fellowship at Johns Hopkins University School of Medicine. She sees patients at the Johns Hopkins Bayview Metabolic Bone and Osteoporosis Center and Green Spring Station Johns Hopkins Endocrinology Clinic (diabetes and thyroid patients only). Dr. Kim is highly rated in 22 conditions, according to our data. Her top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Juvenile Primary Osteoporosis, and Hyperparathyroidism.

Adline Ghazi is an Endocrinologist in Baltimore, Maryland. Dr. Ghazi is highly rated in 18 conditions, according to our data. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Thyroid Hormone Plasma Membrane Transport Defect, and Generalized Resistance to Thyroid Hormone.

Malek Cheikh is an Endocrinologist in Baltimore, Maryland. Dr. Cheikh is highly rated in 16 conditions, according to our data. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Elizabeth Streeten is an Endocrinologist and a Medical Genetics provider in Baltimore, Maryland. Dr. Streeten is highly rated in 15 conditions, according to our data. Her top areas of expertise are Osteoporosis-Pseudoglioma Syndrome, Osteoporosis, Gaucher Disease, and Gaucher Disease Type 3.

David S. Cooper, MD, MACP is a graduate of the Tufts University School of Medicine and completed his endocrinology training at Massachusetts General Hospital and Harvard Medical School. He is currently Professor of Medicine and Radiology at the Johns Hopkins University School of Medicine and Professor of International Health at the Johns Hopkins Bloomberg School of Public Health. He is one of the editors of the iconic textbook on thyroid disease, Werner and Ingbar’s The Thyroid, and he co-edits two other textbooks: Medical Management of Thyroid Disease and Thyroid Cancer. He is also the co-author of a book for patients with thyroid disease entitled Your Thyroid: A Home Reference. He is the past Chair of the Subspecialty Board for Endocrinology, Diabetes, and Metabolism of the American Board of Internal Medicine. He is an Editor-in-Chief for Endocrinology at Up-to-Date, and he has served as the Chair of the Endocrine Society’s annual Board Review Course. Dr. Cooper was the Chair of the American Thyroid Association’s (ATA) 2006 and 2009 task forces that first drafted clinical practice guidelines for the management of thyroid nodules and thyroid cancer. He also served on ATA sponsored task forces that promulgated guidelines for the management of hypothyroidism and for the management of hyperthyroidism. He is the past Treasurer and past President of the ATA, and the recipient of the ATA’s Distinguished Service Award, its Paul Starr Award, and the Lewis Braverman Lectureship Award. He is also the recipient of the Distinction in Endocrinology Award given by the American Association of Clinical Endocrinologists, as well as the Endocrine Society’s Outstanding Scholarly Physician Laureate Award and the Outstanding Educator Laureate Award. Dr. Cooper is highly rated in 11 conditions, according to our data. His top areas of expertise are Thyroid Cancer, Graves Disease, Follicular Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Jennifer Mammen, M.D., Ph.D., Assistant Professor of Medicine, is a member the Division of Endocrinology, Diabetes and Metabolism. Dr. Mammen practices general endocrinology with a focus on thyroid, adrenal and pituitary disorders. She is actively engaged in research on hormonal function and aging. Dr. Mammen is highly rated in 10 conditions, according to our data. Her top areas of expertise are Hyperthyroidism, Hypothyroidism, Thyroid Storm, Graves Disease, and Hormone Replacement Therapy (HRT).

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is highly rated in 7 conditions, according to our data. Her top areas of expertise are Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Rozalina Mccoy is an Endocrinologist in Baltimore, Maryland. Dr. Mccoy has been practicing medicine for over 17 years is highly rated in 7 conditions, according to our data. Her top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is highly rated in 6 conditions, according to our data. Her top areas of expertise are Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy.

Justin Tcheugui is an Endocrinologist in Baltimore, Maryland. Dr. Tcheugui is highly rated in 6 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Gestational Diabetes.

Sherita Golden is an Endocrinologist in Baltimore, Maryland. Dr. Golden is highly rated in 5 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Obesity, and Hormone Replacement Therapy (HRT).

Mihail “Misha” Zilbermint, M.D., M.B.A., F.A.C.E. is an Associate Professor of Clinical Medicine at the Division of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine. He is the Director of Endocrine Hospitalists at the Johns Hopkins Community Physicians, Chief and Director of Division of Endocrinology, Diabetes and Metabolism at Suburban Hospital in Bethesda, MD. Dr. Zilbermint is known for pioneering the Endocrine Hospitalist program at Johns Hopkins Medicine following the completion of his endocrinology fellowship at the National Institutes of Health. This consultation service is dedicated to enhancing glycemic control among hospitalized patients, effectively reducing patient stays and saving the hospital hundreds of thousands of dollars. His commitment to innovation earned his specialized diabetes team the Johns Hopkins Innovations in Clinical Care Award. Over the years, Dr. Zilbermint has been sought after for his expertise in endocrinology and diabetes, with a focus on inpatient diabetes management, diabetic ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and diabetes technology. His reputation extends nationally and internationally, as he is often invited to speak at conferences and is sought after for consultations worldwide. His extensive research interests encompass diabetes initiatives, hypoglycemia reduction, continuous glucose monitoring (CGM) systems, COVID-19 vaccines and hyperglycemia, COVID-19 and diabetes, genetic causes of hypertension, primary aldosteronism, rare adrenal tumors, and the interplay between diabetes and climate change. Dr. Zilbermint leads the JHCP Academy Clinical Excellence, which helps to recognize and promote clinical excellence about community-based clinicians. Beyond his clinical and research contributions, Dr. Zilbermint is a dedicated educator. He imparts his expertise to endocrinology fellows, hospitalists, pharmacy residents, and advanced practice providers, furthering the advancement of the medical community. CVhttps://www.hopkinsmedicine.org/-/media/profiles-support/cvs/zilbermint.pdfLinkedInhttps://www.linkedin.com/in/mishazilbermint. Dr. Zilbermint is highly rated in 5 conditions, according to our data. His top areas of expertise are Cushing's syndrome, Familial Hyperaldosteronism, Hyperaldosteronism, Low Blood Sugar, and Thymectomy.

Dr. Kendall Moseley is the Clinical Director of the Division of Diabetes, Endocrinology & Metabolism, Medical Director of the Johns Hopkins Metabolic Bone & Osteoporosis Center and Co-Director of the Johns Hopkins Multidisciplinary Parathyroid Clinic. Dr. Moseley received her medical degree from Baylor College of Medicine in Houston, TX, followed by internal medicine residency training at the Johns Hopkins Hospital. Upon completion of her endocrinology fellowship at Johns Hopkins, she joined the faculty in the Division of Endocrinology, Diabetes & Metabolism of the Johns Hopkins University School of Medicine. Dr. Moseley has a dynamic clinical practice and collaborations within the institution that focus on metabolic bone diseases, osteoporosis, hyperparathyroidism, vitamin D deficiency, atypical fractures, and skeletal survivorship. She is actively engaged in NIH-funded clinical and translational research involving the relationship between type 2 diabetes, osteoporosis, and aging. She is additionally involved in research investigating mechanisms by which chronic disease states such as malignancy, HIV, hepatitis C, and cystic fibrosis impact bone quantity and quality. Clinically, she enjoys partnering with her patients and using their unique and often complex medical history to individually tailor effective diet, lifestyle, and treatment regimens to improve skeletal health. Dr. Moseley is highly rated in 5 conditions, according to our data. Her top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Paget's Disease of Bone, and Hyperparathyroidism.

Jean Park is an Endocrinologist in Baltimore, Maryland. Dr. Park is highly rated in 5 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Thyroid Storm.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is highly rated in 5 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Mansur Shomali is an Endocrinologist in Baltimore, Maryland. Dr. Shomali is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Paget's Disease of Bone, and Type 1 Diabetes (T1D).

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Maturity Onset Diabetes of the Young, and Pancreaticoduodenectomy.